These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12588327)

  • 1. Carbohydrate-protein conjugate vaccines.
    Ada G; Isaacs D
    Clin Microbiol Infect; 2003 Feb; 9(2):79-85. PubMed ID: 12588327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
    Jakobsen H; Jonsdottir I
    Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
    Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
    Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics.
    Stephens DS
    Trans Am Clin Climatol Assoc; 2011; 122():115-23. PubMed ID: 21686214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
    Bröker M; Berti F; Schneider J; Vojtek I
    Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of newborns with bacterial conjugate vaccines.
    van den Biggelaar AH; Pomat WS
    Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new vaccine concept: polysaccharide conjugate vaccines].
    Moreau M
    Ann Pharm Fr; 1999 May; 57(3):223-31. PubMed ID: 10427857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination conjugate vaccines.
    Bar-Zeev N; Buttery JP
    Expert Opin Drug Saf; 2006 May; 5(3):351-60. PubMed ID: 16610965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated polysaccharide vaccines.
    Ahmad H; Chapnick EK
    Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccines.
    Jones C; Crane DT; Lemercinier X; Bolgiano B; Yost SE
    Dev Biol Stand; 1996; 87():143-51. PubMed ID: 8854011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials.
    Voysey M; Sadarangani M; Clutterbuck E; Bolgiano B; Pollard AJ
    Vaccine; 2016 Jul; 34(34):3986-92. PubMed ID: 27349840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conjugated vaccines].
    Swennen B; Sternon J
    Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.